Although members of the FOS family (predicted as targets of miR-221 and miR-222) are generally associated with oncogenesis, early recurrence, and increased survival of prostatic tumor cells (72, 73), there is no consensus on its role. The gene discussed is FOS; the disease is prostate neoplasm.